P&G Hygiene

Why is Procter & Gamble Hygiene & Health Care Ltd. falling/rising?

As of 13-Jul, Procter & Gamble Hygiene & Health Care Ltd. is facing a stock price decline to 8,909.30, reflecting poor long-term growth and disappointing quarterly results. The stock has underperformed against benchmarks and is considered expensive relative to peers, contributing to negative investor sentiment.

As of 13-Jul, Procter & Gamble Hygiene & Health Care Ltd. is experiencing a decline in its stock price, currently at 8,909.30, which reflects a change of -29.0 (-0.32%). The stock has shown poor long-term growth, with net sales growing at an annual rate of only 4.63% and operating profit at 5.40% over the last five years. Recent quarterly results have also been disappointing, with net sales for the quarter reported at Rs 941.32 crore, indicating a decline of -5.07%, and earnings per share (EPS) at its lowest of Rs 47.17.<BR><BR>Furthermore, the stock has significantly underperformed against the benchmark indices, generating a return of -32.56% over the past year, while the BSE500 index has only declined by -5.92% during the same period. This consistent underperformance over the last three years, coupled with a high price-to-book value ratio of 38.4, suggests that the stock is considered expensive relative to its peers, despite having a high return on equity (ROE) of 82.27%.<BR><BR>Additionally, the stock is trading lower than its moving averages across various time frames, indicating a bearish trend. Although there has been a rise in investor participation, with delivery volume increasing by 9.58% against the five-day average, the overall sentiment remains negative due to the company's flat financial results and lack of growth prospects. Thus, these factors contribute to the current decline in the stock price of Procter & Gamble Hygiene & Health Care Ltd.

Which are the latest news on P&G Hygiene?

How big is P&G Hygiene?

As of 10th June, Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 29,536.00 Cr, with recent net sales of 4,281.59 Cr and a net profit of 856.51 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Procter & Gamble Hygiene & Health Care Ltd. has a market capitalization of 29,536.00 Cr, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 4,281.59 Cr, while the sum of Net Profit for the same period is 856.51 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025, with Shareholder's Funds amounting to 736.99 Cr and Total Assets totaling 1,672.31 Cr.

Who are in the management team of P&G Hygiene?

The management team of P&G Hygiene includes A K Gupta, Sonali Dhawan, Karthik Natarajan, Pramod Agarwal, Gagan Sawhney, Meena Ganesh, Ghanashyam Hedge, Chittranjan Dua, Krishnamurthy Narayanan Iyer, L. V. Vaidyanathan, and Gurcharan Das, featuring a mix of directors and independent directors. If you need details about specific members or their roles, feel free to ask!

The management team of P&G Hygiene includes the following individuals:<BR><BR>1. A K Gupta - Independent Director<BR>2. Sonali Dhawan - Director<BR>3. Karthik Natarajan - Director<BR>4. Pramod Agarwal - Director<BR>5. Gagan Sawhney - Director<BR>6. Meena Ganesh - Independent Director<BR>7. Ghanashyam Hedge - Executive Director & Secretary<BR>8. Chittranjan Dua - Chairman & Independent Director<BR>9. Krishnamurthy Narayanan Iyer - Independent Director<BR>10. L. V. Vaidyanathan - Managing Director<BR>11. Gurcharan Das - Independent Director<BR><BR>This team brings a diverse range of expertise to the company. If you need more specific information about any of the members or their roles, feel free to ask!

Who are the peers of the P&G Hygiene?

P&G Hygiene's peers include Tata Consumer, Godrej Consumer, Dabur India, Colgate-Palmoliv, Godfrey Phillips, Gillette India, Cupid, Hatsun Agro, Emami, and Bikaji Foods. P&G Hygiene has a low 1-year return of -32.82%, while Cupid leads with 698.05%.

Peers: The peers of P&G Hygiene are Tata Consumer, Godrej Consumer, Dabur India, Colgate-Palmoliv, Godfrey Phillips, Gillette India, Cupid, Hatsun Agro, Emami, and Bikaji Foods.<BR><BR>Quality Snapshot: Excellent management risk is observed at Colgate-Palmoliv, Godfrey Phillips, Gillette India, Emami, and P&G Hygiene, while Good management risk is found at Godrej Consumer, Dabur India, and Hatsun Agro. Average management risk is present at Tata Consumer and Cupid. Growth ratings show Excellent growth at Godfrey Phillips, Good growth at Tata Consumer and Cupid, and Below Average growth at Godrej Consumer, Dabur India, Colgate-Palmoliv, P&G Hygiene, Gillette India, Hatsun Agro, Emami, and Bikaji Foods. Capital Structure is rated Excellent for Tata Consumer, Godrej Consumer, Dabur India, Colgate-Palmoliv, Godfrey Phillips, P&G Hygiene, Gillette India, Cupid, and Emami, while Average capital structure is noted for Hatsun Agro.<BR><BR>Return Snapshot: Cupid has the highest 1-year return at 698.05%, while P&G Hygiene has the lowest at -32.82%. This indicates that P&G Hygiene's 1-year return is significantly lower than that of Cupid. Additionally, the six-month return is negative for P&G Hygiene, Godrej Consumer, Dabur India, Colgate-Palmoliv, Godfrey Phillips, Emami, and Hatsun Agro.

What does P&G Hygiene do?

Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) manufactures and sells branded fast-moving consumer goods in the femcare and healthcare sectors. As of March 2026, it reported net sales of 938 Cr and a net profit of 153 Cr, with a market cap of INR 29,536 Cr.

Overview:<BR>Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is engaged in manufacturing and selling branded packaged fast moving consumer goods in the femcare and healthcare sectors, operating within the FMCG industry as a mid-cap company.<BR><BR>History:<BR>P&GHHCL was incorporated in an unspecified year and has maintained its status as a key player in the FMCG sector. The latest quarterly results reported are for March 2026, showcasing the company's performance in net sales and profit.<BR><BR>Financial Snapshot:<BR>- Net Sales: 938 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 153 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 29,536 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: 34.00<BR>- Industry P/E: 45<BR>- Dividend Yield: 2.87%<BR>- Debt Equity: -0.75<BR>- Return on Equity: 113.68%<BR>- Price to Book: 39.04<BR><BR>Contact Details:<BR>Address: P & G Plaza Chakala, Cardinal Gracias Rd Andheri(E) Mumbai Maharashtra : 400099<BR>Tel: 91-22-28266000<BR>Email: investorpghh.i@pg.com<BR>Website: http://www.in.pg.com

Should I buy, sell or hold Procter & Gamble Hygiene & Health Care Ltd.?

Are Procter & Gamble Hygiene & Health Care Ltd. latest results good or bad?

Procter & Gamble Hygiene & Health Care Ltd.'s latest results are disappointing, with a 1.90% decline in net profit and a 5.20% drop in net sales year-on-year, raising concerns about the company's growth in a competitive FMCG market. Despite improved operating margins, the overall performance reflects significant challenges, leading to negative market reactions.

Procter & Gamble Hygiene & Health Care Ltd.'s latest results indicate a challenging period for the company. In the fourth quarter of FY26, the company reported a net profit of ₹153.13 crores, which represents a 1.90% decline year-on-year. Additionally, net sales fell by 5.20% year-on-year to ₹937.67 crores. This decline in sales is particularly concerning as it highlights the company's struggle to drive growth in a competitive FMCG market.<BR><BR>While the operating margin improved to 23.28%, up 208 basis points from the previous year, this was not enough to offset the overall decline in revenue. The full-year performance also reflects significant challenges, with a 19.80% decrease in consolidated net sales compared to the previous fiscal year.<BR><BR>The market reaction has been negative, with the stock trading down significantly and underperforming the FMCG sector. Investors are expressing concerns about the company's stagnant growth trajectory and high valuation, especially given the backdrop of a generally resilient FMCG sector where many competitors are managing to achieve growth.<BR><BR>Overall, the results can be characterized as disappointing, raising questions about the company's competitive positioning and ability to capitalize on market opportunities.

Has Procter & Gamble Hygiene & Health Care Ltd. declared dividend?

Yes, Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend of 1700% (₹65 per share), with an ex-date of February 5, 2026. Despite the significant dividend, total returns have been negative over shorter periods, improving in the long term.

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 1700%<BR>- Amount per share: 65<BR>- Ex-date: 05 Feb 26<BR><BR>Dividend Yield: 1.49%.<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was -11.01%, the dividend return was 0.19%, resulting in a total return of -10.82%.<BR><BR>In the 6-month period, the price return was -14.1%, the dividend return was 0.68%, leading to a total return of -13.42%.<BR><BR>For the 1-year period, the price return was -17.41%, the dividend return was 1.38%, culminating in a total return of -16.03%.<BR><BR>Over the 2-year period, the price return was -30.52%, the dividend return was 1.80%, resulting in a total return of -28.72%.<BR><BR>In the 3-year period, the price return was -13.29%, the dividend return was 3.36%, leading to a total return of -9.93%.<BR><BR>During the 4-year period, the price return was -17.88%, the dividend return was 3.91%, culminating in a total return of -13.97%.<BR><BR>In the 5-year period, the price return was 5.2%, the dividend return was 7.14%, resulting in a total return of 12.34%.<BR><BR>Overall, while Procter & Gamble Hygiene & Health Care Ltd. has declared a significant dividend, the total returns over various periods indicate a trend of negative performance, particularly in the shorter time frames, with a more favorable outcome in the longer term.

Has Procter & Gamble Hygiene & Health Care Ltd. declared dividend?

Yes, Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend of 1700% (₹65 per share) with an ex-date of August 28, 2025. Despite this, the company has experienced negative total returns over the past 1 to 4 years, though it showed a positive return of 12.34% over the last 5 years.

Procter & Gamble Hygiene & Health Care Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 1700%<BR>- Amount per share: 65<BR>- Ex-date: Aug-28-2025<BR><BR>Dividend Yield: 1.49%.<BR><BR>Total Returns by Period:<BR>Over the past 3 months, the price return was -11.01%, the dividend return was 0.19%, resulting in a total return of -10.82%.<BR><BR>In the last 6 months, the price return decreased by -14.1%, with a dividend return of 0.68%, leading to a total return of -13.42%.<BR><BR>For the 1-year period, the price return was -17.41%, the dividend return was 1.38%, culminating in a total return of -16.03%.<BR><BR>Over 2 years, the price return fell by -30.52%, the dividend return was 1.80%, resulting in a total return of -28.72%.<BR><BR>In the 3-year period, the price return was -13.29%, the dividend return was 3.36%, leading to a total return of -9.93%.<BR><BR>For the 4-year period, the price return decreased by -17.88%, with a dividend return of 3.91%, resulting in a total return of -13.97%.<BR><BR>In the 5-year span, the price return increased by 5.2%, the dividend return was 7.14%, leading to a total return of 12.34%.<BR><BR>Overall, while Procter & Gamble Hygiene & Health Care Ltd. has declared a significant dividend, the total returns over various periods indicate a challenging performance, particularly in the shorter terms, with negative returns dominating. However, the 5-year period shows a positive total return, suggesting potential recovery or growth in the long term.

How has been the historical performance of P&G Hygiene?

P&G Hygiene has shown consistent growth in net sales, reaching 4,191.57 Cr in June 2024, but experienced a slight decline in profit after tax and cash flow from operating activities. Total assets and liabilities decreased, indicating potential restructuring despite strong sales performance.

Answer:<BR>The historical performance of P&G Hygiene shows a consistent upward trend in net sales and operating profit over the years, with net sales reaching 4,191.57 Cr in June 2024, up from 3,905.21 Cr in June 2023 and 3,792.45 Cr in June 2022. Operating profit also increased to 1,022.69 Cr in June 2024 from 909.21 Cr in June 2023. However, profit after tax saw a slight decline to 675.02 Cr in June 2024 from 678.14 Cr in June 2023. The company's total assets decreased to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023, while total liabilities also fell to 1,783.69 Cr in June 2024 from 2,071.78 Cr in June 2023. Cash flow from operating activities decreased to 470.00 Cr in June 2024 from 825.00 Cr in June 2023, indicating a tightening in cash generation.<BR><BR>Breakdown:<BR>P&G Hygiene has demonstrated a robust growth trajectory in net sales, which climbed from 3,001.99 Cr in June 2020 to 4,191.57 Cr in June 2024, reflecting a strong demand for its products. Operating profit, excluding other income, also showed a positive trend, increasing from 603.71 Cr in June 2020 to 970.44 Cr in June 2024, although the profit after tax slightly declined in the latest fiscal year. The company's total assets and liabilities both decreased in June 2024 compared to the previous year, suggesting a potential restructuring or reduction in operational scale. Furthermore, cash flow from operating activities has seen a decline, which may indicate challenges in maintaining liquidity despite the growth in sales and profits. Overall, while P&G Hygiene has achieved significant sales growth, the fluctuations in profit margins and cash flow warrant close monitoring.

Is P&G Hygiene technically bullish or bearish?

As of November 3, 2025, P&G Hygiene's trend is mildly bearish, influenced by daily moving averages and monthly MACD signals, despite some mildly bullish indicators on the weekly MACD.

As of 3 November 2025, the technical trend for P&G Hygiene has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages indicating bearish momentum and the monthly MACD showing a bearish signal. The weekly MACD is mildly bullish, but this is offset by the monthly Bollinger Bands and KST both indicating bearish conditions. The RSI shows no signal in both weekly and monthly time frames, suggesting a lack of strong momentum in either direction. Overall, the mixed signals across different indicators reflect a weak bearish sentiment.

Who are the top shareholders of the P&G Hygiene?

The top shareholder of P&G Hygiene is Procter And Gamble Overseas India B.V. with 68.73%. Other significant shareholders include mutual funds at 8.26%, individual investors at 9.76%, and Foreign Institutional Investors at 1.33%.

The top shareholders of P&G Hygiene include Procter And Gamble Overseas India B.V., which holds the largest stake at 68.73%. Additionally, mutual funds collectively hold 8.26% through 15 schemes, with the SBI Focused Equity Fund being the highest public shareholder at 5.73%. Foreign Institutional Investors (FIIs) hold 1.33% through 108 entities, while individual investors account for 9.76% of the shareholding. There are no pledged promoter holdings reported.

When is the next results date for P&G Hygiene?

No Upcoming Board Meetings